التفاصيل البيبلوغرافية
| العنوان: |
Silent risk: the vertical transmission of Oropouche virus. |
| المؤلفون: |
Garima S, Kukreja, Priyanka S, Khopkar-Kale, Srikanth P, Tripathy, Jitendra S, Bhawalkar |
| المصدر: |
European Journal of Clinical Microbiology & Infectious Diseases; Jan2025, Vol. 44 Issue 1, p209-211, 3p |
| مصطلحات موضوعية: |
MEDICAL sciences, MEDICAL microbiology, VACCINE approval, PREGNANT women, PUBLIC health |
| مستخلص: |
The Oropouche virus (OROV), a member of the Orthobunyavirus genus, poses a significant public health challenge due to its potential for vertical transmission and lack of approved vaccines or antiviral treatments. Recent outbreaks have highlighted the association of OROV infection in pregnant women with severe outcomes, including spontaneous abortions, congenital anomalies, and fetal deaths. This letter to the editor emphasizes the need for a multifaceted approach to address the potential for vertical transmission of OROV, including the use of small animal models, detailed pathological studies, and robust preventive measures. We stress the importance of increased clinician awareness, timely patient management, and a One Health surveillance program to mitigate the risks associated with OROV infection during pregnancy. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Journal of Clinical Microbiology & Infectious Diseases is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |